HS-1371, a Novel Kinase Inhibitor of RIP3-mediated Necroptosis

Experimental & Molecular Medicine
doi 10.1038/s12276-018-0152-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

RIP1/RIP3-regulated Necroptosis as a Target for Multifaceted Disease Therapy (Review)

International Journal of Molecular Medicine
MedicineGenetics
2019English

Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis

Cells
2019English

2-Hg Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

A Novel Anti-Melanoma SRC-family Kinase Inhibitor

Oncotarget
Oncology
2019English

Axonal Degeneration Is Mediated by Necroptosis Activation Necroptosis Mediates Axonal Degeneration

Journal of Neuroscience
Neuroscience
2019English

Receptor-Interacting Serine-Threonine Kinase 3 (RIPK3; RIP3)

Science-Business eXchange
2009English

Kinase Domain Dimerization Drives RIPK3-dependent Necroptosis

Science Signaling
BiochemistryCell BiologyMolecular Biology
2018English

Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity

Cancer Research
Cancer ResearchOncology
2013English

Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34

Angewandte Chemie
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy